Home > Back to Publisher > Report Information

Dermatologic & Skin Therapeutics: World Markets & Advances

PJB Publications USA Inc.
September 1, 2003
200 Pages - SKU: VB924672

Abstract Table of Contents Search inside this report Related Reports Buy by the Section

To purchase, check the box next to the section then click the "add section to cart" button. Learn more.

Dermatologic and Skin Therapeutics

1 Executive Summary (pp. 11-15) US $58.00
- 1.1 Scope and Objectives of the Report
- 1.2 Methodology
- 1.3 A Look at Dermatologic/Skin Therapeutics
2 Overview (pp. 15-25) US $700.00
- 2.1 Definition and Types of Dermatologic Diseases
  - 2.1.1 Definition
  - 2.1.2 Disease/Disorder Types Covered
- 2.2 Pathology of Dermatologic Diseases
- 2.3 Prevalence and Demographics
- 2.4 Issues and Trends in Dermatologic Diseases
  - 2.4.1 Health and Economic Consequences of Dermatologic Diseases
  - 2.4.2 Regulatory and Legislative Actions for Dermatologic Diseases
  - 2.4.3 Grassroots/Public Awareness Campaigns for Dermatologic Diseases
  - 2.4.4 Industry Actions for Dermatologic Diseases
3 Psoriasis (pp. 25-63) US $700.00
- 3.1 Overview
  - 3.1.1 Plaque-Type Psoriasis
  - 3.1.2 Guttate Psoriasis
  - 3.1.3 Pustular Psoriasis
  - 3.1.4 Erythrodermic Psoriasis
  - 3.1.5 Nail Psoriasis
  - 3.1.6 Psoriatic Arthritis
- 3.2 Risk Factors
- 3.3 Incidence and Mortality
- 3.4 Treatments for Psoriasis
  - 3.4.1 Calcipotriol
  - 3.4.2 Corticosteroids
  - 3.4.3 Other Topical Agents
  - 3.4.4 Oral Systemic Drugs
  - 3.4.5 Phototherapy
- 3.5 Research and Development
- 3.6 Market Analysis for Psoriasis Drugs
  - 3.6.1 Total World Market Size and Growth
  - 3.6.2 U.S. Market Size and Growth
  - 3.6.3 Western European Market Size and Growth
  - 3.6.4 Japanese Market Size and Growth
  - 3.6.5 Rest of World Market Size and Growth
- 3.7 Competitor Analysis
4 Scleroderma (pp. 63-99) US $700.00
- 4.1 Overview
  - 4.1.1 Localized Scleroderma
  - 4.1.2 Systemic Scleroderma
- 4.2 Risk Factors
- 4.3 Incidence and Mortality
- 4.4 Treatments for Scleroderma
  - 4.4.1 ACE Inhibitors
  - 4.4.2 DMARDs
  - 4.4.3 Calcium Channel Blockers
  - 4.4.4 Other Medications
- 4.5 Research and Development
- 4.6 Market Analysis for Scleroderma Drugs
  - 4.6.1 Total World Market Size and Growth
  - 4.6.2 U.S. Market Size and Growth
  - 4.6.3 Western European Market Size and Growth
  - 4.6.4 Japanese Market Size and Growth
  - 4.6.5 Rest of World Market Size and Growth
- 4.7 Competitor Analysis
5 Eczema/Atopic Dermatitis (pp. 99-133) US $700.00
- 5.1 Overview
- 5.2 Risk Factors
- 5.3 Incidence and Mortality
- 5.4 Treatments for Eczema/Atopic Dermatitis
  - 5.4.1 Topical Steroids
  - 5.4.2 Oral Steroids
  - 5.4.3 Immunomodulators
  - 5.4.4 Other Medications
  - 5.4.5 Light Therapy
- 5.5 Research and Development
- 5.6 Market Analysis for Atopic Dermatitis Drugs
  - 5.6.1 Total World Market Size and Growth
  - 5.6.2 U.S. Market Size and Growth
  - 5.6.3 Western European Market Size and Growth
  - 5.6.4 Japanese Market Size and Growth
  - 5.6.5 Rest of World Market Size and Growth
- 5.7 Competitor Analysis
6 Acne (pp. 133-169) US $700.00
- 6.1 Overview
- 6.2 Risk Factors
- 6.3 Incidence and Mortality
- 6.4 Treatments for Acne
  - 6.4.1 Accutane
  - 6.4.2 Retinoids
  - 6.4.3 Antibiotics
  - 6.4.4 OTC Treatments
  - 6.4.5 Oral Contraceptives
- 6.5 Research and Development
- 6.6 Market Analysis for Acne Drugs
  - 6.6.1 Total World Market Size and Growth
  - 6.6.2 U.S. Market Size and Growth
  - 6.6.3 Western European Market Size and Growth
  - 6.6.4 Japanese Market Size and Growth
  - 6.6.5 Rest of World Market Size and Growth
- 6.7 Competitor Analysis
7 Skin Cancer (pp. 169-205) US $700.00
- 7.1 Overview
  - 7.1.1 Melanoma
  - 7.1.2 Basal Cell Carcinoma
  - 7.1.3 Squamous Cell Carcinoma
  - 7.1.4 Actinic Keratoses
- 7.2 Risk Factors
- 7.3 Incidence and Mortality
- 7.4 Treatments for Skin Cancer
  - 7.4.1 Topical Antimetabolites
  - 7.4.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
  - 7.4.3 Chemotherapy
  - 7.4.4 Immunotherapy
  - 7.4.5 Surgery and Cryosurgery
  - 7.4.6 Radiation
- 7.5 Research and Development
- 7.6 Market Analysis for Skin Cancer Drugs
  - 7.6.1 Total World Market Size and Growth
  - 7.6.2 U.S. Market Size and Growth
  - 7.6.3 Western European Market Size and Growth
  - 7.6.4 Japanese Market Size and Growth
  - 7.6.5 Rest of World Market Size and Growth
- 7.7 Competitor Analysis
8 Total Market Summary (pp. 205-223) US $700.00
- 8.1 Total Global Market by Disease/Condition
- 8.2 Total Global Market by Geographic Region
- 8.3 Competitive Analysis
9 Company Briefs (pp. 223-254) US $700.00
- 9.1 Allergan, Inc.
- 9.2 AstraZeneca
- 9.3 Bayer AG
- 9.4 Bristol-Myers Squibb Co.
- 9.5 Dermik Laboratories, Inc.
- 9.6 Fujisawa Japan
- 9.7 Galderma Laboratories L.P.
- 9.8 GlaxoSmithKline
- 9.9 Merck & Co., Inc.
- 9.10 Novartis AG
- 9.11 Ortho-McNeil Pharmaceutical, Inc.
- 9.12 Pfizer, Inc.
- 9.13 Pharmacia Corp.
- 9.14 Hoffmann-La Roche, Inc.
- 9.15 Schering-Plough Corp.

Dermatologic & Skin Therapeutics: World Markets & Advances

Share this report

Other tasks

Research Assistance

Related Markets

Dermatology Reports

Free Alert Me service